Overall, data from our gene expression analyses allude to a possibility that the death and/or cell cycle arrest in chemoresistant/refractory DLBCL cells triggered by selective inhibition of HDAC1,2 activity is from the activation of DNA damage response potentially resulting from endogenous DNA breaks. The gene discussed is HDAC1; the disease is diffuse large B-cell lymphoma.